Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.
Dominic BettingerRenan SpodeNicolas GlaserNico BuettnerTobias BoettlerChristoph Neumann-HaefelinThomas Baptist BrunnerEleni GkikaLars MaruschkeRobert ThimmeMichael SchultheissPublished in: BMC gastroenterology (2017)
In metastatic HCC, treatment of intrahepatic tumor by TACE may be associated with improved survival. These results support the prognostic importance of treating intrahepatic HCC even in patients with metastatic disease. Therefore, we suggest evaluating the technical feasibility of TACE in all metastatic patients.